IRONWOOD PHARMACEUTICALS, INC. Increase (Decrease) in Receivables
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Increase (Decrease) in Receivables of -$7.99 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2023-02-16
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in receivables for the quarter ending 2022-12-31 was -$937.00K, a 107.55% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in receivables for the quarter ending 2022-09-30 was $14.34M.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in receivables for the quarter ending 2022-06-30 was -$3.01M, a 119.76% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in receivables for the quarter ending 2022-03-31 was -$18.38M.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in receivables for fiscal 2022 was -$7.99M.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in receivables for fiscal 2021 was -$7.71M.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in receivables for fiscal 2020 was -$4.09M, a 105.94% decline from fiscal 2019.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in receivables for fiscal 2019 was $68.89M.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$937.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $13.40M derived: sum of 2 quarters · filed 2023-02-16 | $10.39M derived: sum of 3 quarters · filed 2023-02-16 | -$7.99M 10-K · filed 2023-02-16 |
| 2022-09-30 | $14.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $11.33M derived: sum of 2 quarters · filed 2022-11-03 | -$7.06M 10-Q · filed 2022-11-03 | $5.36M derived: sum of 4 quarters · filed 2023-02-16 |
| 2022-06-30 | -$3.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$21.39M 10-Q · filed 2022-08-04 | -$8.98M derived: sum of 3 quarters · filed 2023-02-16 | -$9.31M derived: sum of 4 quarters · filed 2023-02-16 |
| 2022-03-31 | -$18.38M 10-Q · filed 2022-05-05 | -$5.97M derived: sum of 2 quarters · filed 2023-02-16 | -$6.30M derived: sum of 3 quarters · filed 2023-02-16 | $8.94M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-12-31 | $12.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $12.08M derived: sum of 2 quarters · filed 2023-02-16 | $27.32M derived: sum of 3 quarters · filed 2023-02-16 | -$7.71M 10-K · filed 2023-02-16 |
| 2021-09-30 | -$333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $14.91M derived: sum of 2 quarters · filed 2022-11-03 | -$20.13M 10-Q · filed 2022-11-03 | -$10.82M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $15.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$19.79M 10-Q · filed 2022-08-04 | -$10.49M derived: sum of 3 quarters · filed 2023-02-16 | -$2.42M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$35.04M 10-Q · filed 2022-05-05 | -$25.73M derived: sum of 2 quarters · filed 2023-02-16 | -$17.66M derived: sum of 3 quarters · filed 2023-02-16 | -$3.19M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $17.38M derived: sum of 2 quarters · filed 2023-02-16 | $31.85M derived: sum of 3 quarters · filed 2023-02-16 | -$4.09M 10-K · filed 2023-02-16 |
| 2020-09-30 | $8.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $22.55M derived: sum of 2 quarters · filed 2021-11-04 | -$13.40M 10-Q · filed 2021-11-04 | $8.79M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $14.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$21.47M 10-Q · filed 2021-08-05 | $712.00K derived: sum of 3 quarters · filed 2022-02-18 | $25.89M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | -$35.94M 10-Q · filed 2021-05-06 | -$13.76M derived: sum of 2 quarters · filed 2022-02-18 | $11.42M derived: sum of 3 quarters · filed 2022-02-18 | $41.28M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $22.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $47.36M derived: sum of 2 quarters · filed 2022-02-18 | $77.23M derived: sum of 3 quarters · filed 2022-02-18 | $68.89M 10-K · filed 2022-02-18 |
| 2019-09-30 | $25.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $55.05M derived: sum of 2 quarters · filed 2020-11-05 | $46.71M 10-Q · filed 2020-11-05 | $62.29M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | $29.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $21.53M 10-Q · filed 2020-08-06 | $37.10M derived: sum of 3 quarters · filed 2021-02-17 | $21.96M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | -$8.33M 10-Q · filed 2020-05-06 | $7.24M derived: sum of 2 quarters · filed 2021-02-17 | -$7.90M derived: sum of 3 quarters · filed 2021-02-17 | $1.97M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-31 | $15.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $431.00K derived: sum of 2 quarters · filed 2021-02-17 | $10.30M derived: sum of 3 quarters · filed 2021-02-17 | -$1.21M 10-K · filed 2021-02-17 |
| 2018-09-30 | -$15.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$5.28M derived: sum of 2 quarters · filed 2019-10-31 | -$16.78M 10-Q · filed 2019-10-31 | -$14.71M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $9.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | -$1.64M 10-Q · filed 2019-07-30 | $436.00K derived: sum of 3 quarters · filed 2020-02-13 | $20.16M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | -$11.51M 10-Q · filed 2019-05-02 | -$9.43M derived: sum of 2 quarters · filed 2020-02-13 | $10.29M derived: sum of 3 quarters · filed 2020-02-13 | $19.50M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $21.80M derived: sum of 2 quarters · filed 2020-02-13 | $31.01M derived: sum of 3 quarters · filed 2020-02-13 | $17.30M 10-K · filed 2020-02-13 |
| 2017-09-30 | $19.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $28.94M derived: sum of 2 quarters · filed 2018-11-06 | $15.23M 10-Q · filed 2018-11-06 | $26.37M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $9.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$4.50M 10-Q · filed 2018-08-06 | $6.64M derived: sum of 3 quarters · filed 2019-02-25 | $7.21M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | -$13.71M 10-Q · filed 2018-05-04 | -$2.57M derived: sum of 2 quarters · filed 2019-02-25 | -$2.00M derived: sum of 3 quarters · filed 2019-02-25 | -$1.87M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $11.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $11.71M derived: sum of 2 quarters · filed 2019-02-25 | $11.84M derived: sum of 3 quarters · filed 2019-02-25 | $10.34M 10-K · filed 2019-02-25 |
| 2016-09-30 | $568.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $697.00K derived: sum of 2 quarters · filed 2017-11-02 | -$803.00K 10-Q · filed 2017-11-02 | $16.74M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$1.37M 10-Q · filed 2017-08-03 | $16.18M derived: sum of 3 quarters · filed 2018-02-22 | $26.10M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | -$1.50M 10-Q · filed 2017-05-08 | $16.05M derived: sum of 2 quarters · filed 2018-02-22 | $25.97M derived: sum of 3 quarters · filed 2018-02-22 | $19.17M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $17.55M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $27.47M derived: sum of 2 quarters · filed 2018-02-22 | $20.67M derived: sum of 3 quarters · filed 2018-02-22 | $28.68M 10-K · filed 2018-02-22 |
| 2015-09-30 | $9.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $3.12M derived: sum of 2 quarters · filed 2016-11-07 | $11.13M 10-Q · filed 2016-11-07 | $22.29M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-06-30 | -$6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $1.21M 10-Q · filed 2016-08-08 | $12.36M derived: sum of 3 quarters · filed 2017-02-22 | $23.65M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-03-31 | $8.01M 10-Q · filed 2016-05-10 | $19.16M derived: sum of 2 quarters · filed 2017-02-22 | $30.45M derived: sum of 3 quarters · filed 2017-02-22 | $24.57M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-12-31 | $11.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $22.44M derived: sum of 2 quarters · filed 2017-02-22 | $16.56M derived: sum of 3 quarters · filed 2017-02-22 | $23.68M 10-K · filed 2017-02-22 |
| 2014-09-30 | $11.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $5.40M derived: sum of 2 quarters · filed 2015-11-05 | $12.53M 10-Q · filed 2015-11-05 | $12.65M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | -$5.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.24M 10-Q · filed 2015-08-07 | $1.37M derived: sum of 3 quarters · filed 2016-02-19 | -$843.00K derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $7.12M 10-Q · filed 2015-05-06 | $7.25M derived: sum of 2 quarters · filed 2016-02-19 | $5.04M derived: sum of 3 quarters · filed 2016-02-19 | $10.29M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$2.08M derived: sum of 2 quarters · filed 2016-02-19 | $3.17M derived: sum of 3 quarters · filed 2016-02-19 | $1.73M 10-K · filed 2016-02-19 |
| 2013-09-30 | -$2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $3.04M derived: sum of 2 quarters · filed 2014-11-05 | $1.60M 10-Q · filed 2014-11-05 | $2.90M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | $5.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $3.81M 10-Q · filed 2014-08-05 | $5.12M derived: sum of 3 quarters · filed 2015-02-18 | $2.83M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | -$1.44M 10-Q · filed 2014-04-29 | -$134.00K derived: sum of 2 quarters · filed 2015-02-18 | -$2.42M derived: sum of 3 quarters · filed 2015-02-18 | -$61.00K derived: sum of 4 quarters · filed 2015-02-18 |
| 2012-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | -$979.00K derived: sum of 2 quarters · filed 2015-02-18 | $1.38M derived: sum of 3 quarters · filed 2015-02-18 | $835.00K 10-K · filed 2015-02-18 |
| 2012-09-30 | -$2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $73.00K derived: sum of 2 quarters · filed 2013-10-28 | -$470.00K 10-Q · filed 2013-10-28 | -$559.00K derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-06-30 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $1.81M 10-Q · filed 2013-08-08 | $1.73M derived: sum of 3 quarters · filed 2014-02-07 | |
| 2012-03-31 | -$543.00K 10-Q · filed 2013-04-23 | -$632.00K derived: sum of 2 quarters · filed 2014-02-07 | ||
| 2011-12-31 | -$89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | -$2.24M 10-K · filed 2014-02-07 | ||
| 2011-09-30 | -$2.15M 10-Q · filed 2012-11-06 | |||
| 2010-12-31 | -$2.32M 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |